Bank of New York Mellon Corp
BankPosition in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1390777
NEW YORK, NY
Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$472,950,091
-$118,437,054 QoQ
Shares Held
758,492
-0.9% QoQ
Ownership
0.737%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#25
of 1,322 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 91%
Shared 0%
None 9%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names. REGN ranks #2 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $472,950,091 | 758,492 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $591,387,145 | 765,411 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $589,895,462 | 764,242 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $377,637,391 | 671,630 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $344,727,600 | 656,624 | Shares | Defined | 2025-08-05 | |
| 2025-03-31 | $442,852,991 | 698,253 | Shares | Defined | 2025-04-29 | |
| 2024-12-31 | $490,982,706 | 689,263 | Shares | Defined | 2025-02-04 | |
| 2024-09-30 | $751,716,485 | 715,076 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $908,344,260 | 864,242 | Shares | Defined | 2024-07-25 | |
| 2024-03-31 | $853,289,723 | 886,544 | Shares | Other | 2024-04-25 | |
| 2023-12-31 | $833,123,926 | 948,575 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $796,143,016 | 967,414 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $693,210,018 | 964,748 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $816,713,676 | 993,968 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $710,286,696 | 984,472 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $704,523,873 | 1,022,724 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $566,218,002 | 957,857 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $640,491,641 | 917,058 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $558,277,566 | 884,022 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $533,051,616 | 880,815 | Shares | Defined | 2021-11-18 | |
| 2021-06-30 | $479,571,375 | 858,616 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $400,294,413 | 846,038 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $400,142,614 | 828,264 | Shares | Other | 2021-02-09 | |
| 2020-09-30 | $459,090,123 | 820,126 | Shares | Other | 2020-11-12 | |
| 2020-06-30 | $482,175,617 | 773,151 | Shares | Defined | 2020-08-12 | |
| 2020-03-31 | $299,107,893 | 612,562 | Shares | Other | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||